BIOGEN valuation updated with ADUHELM coming in the pipeline 🧪
📓As from Monday, 7th June, the FDA approved the molecule Aducanumab (branded as ADUHELM) for the treatment of Alzheimer’s disease under a quicker than usual pathway generally reserved for oncologic drugs (the Accelerated Approval pathway).
Aduhelm... Mostrar más Traducir
Brief news - Biggest moves pre-market 18/06/2021
$ADBE (Adobe Systems Inc) Adobe reported quarterly profit of $3.03 per share, 21 cents a share above estimates. The software company’s revenue also topped Wall Street forecasts and Adobe gave stronger-than-expected current-quarter guidance. Its shares... Mostrar más Traducir
Ocugen $OCGN (Ocugen Inc) rises after selecting Jubilant HollisterStier as its manufacturing partner for COVAXIN to prepare for the potential commercial manufacturing of the COVID-19 vaccine for the U.S. and Canadian markets
Elanco $ELAN (Elanco Animal Health Inc) gains after selling two facilities... Mostrar más Traducir